UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058039
Receipt number R000066335
Scientific Title Verification of the Effects of L300Go Functional Electrical Stimulation Device on Gait Function in Children with Cerebral Palsy
Date of disclosure of the study information 2025/06/15
Last modified on 2025/06/01 16:59:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effectiveness of the L300Go Walking Support Device in Children with Cerebral Palsy

Acronym

L300Go Gait Support Study for Children with Cerebral Palsy

Scientific Title

Verification of the Effects of L300Go Functional Electrical Stimulation Device on Gait Function in Children with Cerebral Palsy

Scientific Title:Acronym

Interventional study (Treatment)

Region

Japan


Condition

Condition

Cerebral Palsy

Classification by specialty

Rehabilitation medicine Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effectiveness of the L300Go functional electrical stimulation device in improving gait function in children with cerebral palsy (GMFCS Level I-II).

Basic objectives2

Others

Basic objectives -Others

To assess the usability and satisfaction of the L300Go device among pediatric patients and their caregivers, and to explore changes in muscle activity and actual usage conditions during home-based training.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes in gait function before and after using the L300Go (walking speed, step length, gait symmetry)

Key secondary outcomes

Muscle activity (surface electromyography)
User and caregiver satisfaction with device use
Usage status during home use (e.g., wearing time)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Functional gait training using the L300Go functional electrical stimulation device will be provided to children with cerebral palsy (ages 6-12) in both hospital and home settings. Gait function will be assessed before and after the intervention, including walking speed, step length, and gait symmetry.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit

12 years-old >=

Gender

Male and Female

Key inclusion criteria

Children aged 6-12 years diagnosed with cerebral palsy
Classified as GMFCS Level I or II
Without visual or intellectual impairment
Receiving gait training with the L300Go at Tobu Ryoiku Center
Able to provide informed consent and assent

Key exclusion criteria

Difficulty walking due to recent fractures, etc.
High frequency of epileptic seizures that may interfere with gait training
Risk of skin complications from using the L300Go

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Tomoko
Middle name
Last name Sakai

Organization

Institute of Science Tokyo

Division name

Department of Rehabilitation Medicine

Zip code

112

Address

1-5-45, Bunkyo-ku, Tokyo

TEL

0358035648

Email

t_sakai.orth@tmd.ac.jp


Public contact

Name of contact person

1st name Tomoko
Middle name
Last name Sakai

Organization

Institute of Science Tokyo

Division name

Department of Rehabilitation Medicine

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

0358035648

Homepage URL


Email

t_sakai.orth@tmd.ac.jp


Sponsor or person

Institute

Institute of Science Tokyo

Institute

Department

Personal name

Tomoko Sakai


Funding Source

Organization

others

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Tokyo University of Science

Address

1-5-45, Yushima,

Tel

0358035648

Email

rinri.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2025 Year 07 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 01 Day

Last modified on

2025 Year 06 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066335